Andrew A. Hindman, SVP, CHIEF FINANCIAL OFFICER at Theravance Biopharma, Inc. (TBPH), sold 90,057 shares at $11.02 ($988K) on 2022-11-18, disclosed to the SEC on 2022-11-22.
Open-market sale of $988k TBPH by SVP, CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.02 | 65,000 | $716K | 72.5% |
| 2 | $10.85 | 25,057 | $272K | 27.5% |
| Total | $10.97 avg | 90,057 | $988K | 100% |
| Filing → |
| ACOR | SELL | 2017-12-05 | $17K | — | Filing → |
| ACOR | SELL | 2017-05-17 | $121K | — | Filing → |
| ACOR | SELL | 2016-12-05 | $9K | — | Filing → |